Usefulness of the administration of intravenous iron sucrose for the correction of preoperative anemia in major surgery patients;Utilidad de la administración de hierro sacarosa intravenoso para la corrección de la anemia preoperatoria en pacientes programados para cirugía mayor

Medicina Clinica

Volumn 132, Issue 8, 2009, Pages 303-306

  Muñoz, Manuel ^a   García Erce, José A ^b   Díez Lobo, Ana I ^c   Campos, Arturo ^d   Sebastianes, Carmen ^e   Bisbe, Elvira ^f  

^a UNIVERSIDAD DE MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c HOSPITAL GENERAL DE SEGOVIA   (Spain)

^d HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^e HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

^f HOSPITAL DE L ESPERANÇA   (Spain)

Author keywords

Intravenous iron; Iron deficiency; Major surgery; Preoperative anemia

Indexed keywords

FERRIC HYDROXIDE SUCROSE; HEMOGLOBIN;

ABDOMINAL HYSTERECTOMY; ADULT; ANEMIA; ARTHROPLASTY; ARTICLE; COLON RESECTION; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE CARE; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

ANEMIA, IRON-DEFICIENCY; FEMALE; FERRIC COMPOUNDS; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; MALE; MIDDLE AGED; PREOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 60949083186     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2008.04.011     Document Type: Article

References (10)

1. Shander A., Knight K., Thurer R., Adamson J., and Spence R. Prevalence and outcomes of anemia in surgery: a systematic review of the literature. Am J Med 116 (2004) 58S-69S
2. García-Erce J.A., Cuenca J., and Solano V.M. Factores de riesgo transfusional en la fractura subcapital de cadera en pacientes de más de 65 años. Med Clin (Barc) 120 (2003) 161-166
3. Beris P., Muñoz M., García-Erce J.A., Thomas D., Maniatis A., and Van der Linden P. Anaemia management in surgery - consensus statement on the role of intravenous iron. Br J Anaesth 100 (2008) 599-604
4. Muñoz M., Breymann C., García-Erce J.A., Gómez-Ramírez S., Comin J., and Bisbe E. Efficacy and safety of intravenous iron therapy as an alternative/adjunct to allogeneic blood transfusion. Vox Sang 94 (2008) 172-183
5. Goodnough L.T., Skikne B., and Brugnara C. Erythropoietin, iron, and erythropoiesis. Blood 96 (2000) 823-833
6. Stainsby D., Jones H., Asher D., Atterbury C., Boncinelli A., Brant L., et al. SHOT Steering Group. A decade of hemovigilance in the UK. Transfus Med Rev 20 (2006) 272-282
7. Páramo J.A., Lecumberri R., Hernández M., and Rocha E. Alternativas farmacológicas a la transfusión sanguínea. Qué hay de nuevo? Med Clin (Barc) 122 (2004) 231-236
8. Weiss G., and Goodnough L.T. Anemia of chronic disease. N Engl J Med 352 (2005) 1011-1023
9. Chertow G.M., Mason P.D., Vaaga-Nilsen O., and Ahlmén J. Update on adverse drug events associated with parenteral iron. Nephrol Dial Transplant 21 (2006) 378-382
10. Leal R., Alberca I., Asuero M.S., Boveda J.L., Carpio N., Contreras E., et al. Documento «Sevilla» de Consenso sobre alternativas a la transfusión alogénica. Med Clin (Barc) 127 Supl 1 (2006) 3-20